Comparative evaluation of equine mesenchymal stem cells derived from amniotic fluid and umbilical cord blood

BALDEV R GULATI; RAJESH KUMAR; NIHARIKA MOHANTY; SANDEEP GERA; PAWAN KUMAR; PREM S YADAV

doi:10.56093/ijans.v86i5.58483

Authors

BALDEV R GULATI National Research Centre on Equines, Hisar, Haryana 125 001 India
RAJESH KUMAR National Research Centre on Equines, Hisar, Haryana 125 001 India
NIHARIKA MOHANTY National Research Centre on Equines, Hisar, Haryana 125 001 India
SANDEEP GERA LLR University of Veterinary and Animal Sciences, Hisar, Haryana
PAWAN KUMAR Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana
PREM S YADAV Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana

https://doi.org/10.56093/ijans.v86i5.58483

Keywords:

Amniotic fluid, Comparison, Equine, Mesenchymal stem cell, Umbilical cord blood

Abstract

Mesenchymal stem cells (MSCs) are promising therapeutic tools for the treatment of tendon rupture and other musculoskeletal injuries in horses. Although MSCs from bone marrow and adipose tissues are commonly used for therapeutic purpose in equines, umbilical cord blood (UCB) and amniotic fluid (AF) are potential non-invasive sources of MSCs. We collected AF and UCB from twenty mares during foaling for isolation of MSCs and evaluated them for the differences in isolation rates, proliferation capacity, expression of MSC markers and multi-lineage differentiation ability. The plastic adherent colonies were observed in 60% AF and 65% UCB samples. The mean doubling time for AF cells was significantly lower than that of UCB cells. The AF-MSCs proliferated till passage 36 whereas UCB-MSCs till passage 20 only. Both AF and UCB derived cells expressed CD29, CD44, CD73, CD90 and CD105 and were negative for haematopoietic and leukocytic markers (CD14, CD34 and CD45). The CD90 and CD73 expression was significantly higher in AF derived cells as compared to UCB-MSCs. On the other hand, CD29 expression was significantly lower in AF derived cells as compared to UCB derived cells. The UCB-MSCs differentiated poorly to adipogenic lineage compared to AF-MSCs. These results suggested that equine AF yields more MSCs with greater in vitro proliferation and differentiation capacities and is better non-invasive source of MSCs for regenerative therapies in equines.

Downloads

Download data is not yet available.

References

Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C and Brehm W. 2013. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources. Veterinary Journal 195: 98–106. DOI: https://doi.org/10.1016/j.tvjl.2012.06.004

Corradetti B, Meucci A, Bizzaro D, Cremonesi F and Lange C A. 2013. Mesenchymal stem cells from amnion and amniotic fluid in the bovine. Reproduction 145: 391–400. DOI: https://doi.org/10.1530/REP-12-0437

De C P, Bartsch G, Jr Siddiqui M M, Xu T, Santos, C C, Perin L, Mostoslavsk G, Serre A C, Snyder E Y, Yoo J J, Furth M E, Soker S and Atala A. 2007. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology 25: 100– 06. DOI: https://doi.org/10.1038/nbt1274

Docheva D, Hunziker E B, Fassler R and Brandau O. 2005. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Molecular cell Biology 25: 699–705. DOI: https://doi.org/10.1128/MCB.25.2.699-705.2005

Gulati B R, Kumar R, Mohanty N, Kumar P, Somasundaram R K and Yadav P S. 2013. Bone morphogenetic protein-12 induces tenogenic differentiation of mesenchymal stem cells derived from equine amniotic fluid. Cells Tissues Organs 198: 377– 89. DOI: https://doi.org/10.1159/000358231

Iacono E, Brunori L, Pirrone A, Pagliaro P P, Ricci F, Tazzari P L and Merlo B. 2012. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton’s jelly in the horse. Reproduction 143: 455–68. DOI: https://doi.org/10.1530/REP-10-0408

Koch T G, Heerkens T, Thomsen P D and Betts D H. 2007. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnology 7: 26. DOI: https://doi.org/10.1186/1472-6750-7-26

Lange-Consiglio A, Corradetti B, Bizzaro D, Magatti M, Ressel L, Tassan S, Parolini O and Cremonesi F. 2012. Characterization and potential applications of progenitor- like cells isolated from horse amniotic membrane. Journal of Tissue Engineering and Regenerative Medicine 6: 622–35. DOI: https://doi.org/10.1002/term.465

Lovati A B, Corradetti B, Lange C A, Recordati C, Bonacina E, Bizzaro D and Cremonesi F. 2011. Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells. Veterinary Research Communication 35: 103– 21. DOI: https://doi.org/10.1007/s11259-010-9457-3

Mohanty N, Gulati B R, Kumar R, Gera S, Kumar S, Kumar P and Yadav P S. 2014. Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood. Cytotechnology DOI 10.1007/s10616–014-9831–z-. DOI: https://doi.org/10.1007/s10616-014-9831-z

Pappa K I and Anagnou N P. 2009. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regenerative Medicine 4: 423–33. DOI: https://doi.org/10.2217/rme.09.12

Park S B, Seo M S, Kang J G, Chae J S and Kang K S. 2011. Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. Cytotherapy 13: 341–49. DOI: https://doi.org/10.3109/14653249.2010.520312

Ranera B, Lyahyai J, Romero A, Vazquez F J, Remacha A R, Bernal M L, Zaragoza P, Rodellar C and Martin-Burriel I. 2011. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue. Veterinary Immunology and Immunopathology 144: 147–54. DOI: https://doi.org/10.1016/j.vetimm.2011.06.033

Reed S A and Johnson S E. 2008. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. Journal of Cellular Physiology 215: 329–36. DOI: https://doi.org/10.1002/jcp.21312